Maternal Febrile Illnesses, Medication Use, and the Risk of Congenital Renal Anomalies

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 11, 2003, Pages 911-918

  Abe, Karon ^a   Honein, Margaret A ^a   Moore, Cynthia A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Maternal illness; Medication; Renal anomalies

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; CODEINE; DIAZEPAM; MULTIVITAMIN; ORAL CONTRACEPTIVE AGENT; PARACETAMOL DERIVATIVE; PENICILLIN G; TETRACYCLINE;

ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; FLU LIKE SYNDROME; HUMAN; HYDRONEPHROSIS; HYDROURETER; INFANT; KIDNEY AGENESIS; KIDNEY ANOMALY; KIDNEY DUPLICATION; MAJOR CLINICAL STUDY; MALE; MULTICYSTIC DYSPLASTIC KIDNEY; MULTIVARIATE ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL;

ABNORMALITIES; ANALGESICS, NON-NARCOTIC; CASE-CONTROL STUDIES; ENVIRONMENT; FEMALE; FEVER; HUMANS; INFANT, NEWBORN; KIDNEY; KIDNEY DISEASES; MALE; MATERNAL EXPOSURE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; RISK FACTORS;

EID: 0344443786     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10130     Document Type: Article

References (61)

1. Battin M, Albersheim S, Newman D. 1995. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol 12:425-428.
2. Botto LD, Erickson JD, Mulinare J, et al. 2002. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology 13:485-488.
3. Brouhard BH. 1994. Cocaine ingestion and abnormalities of the urinary tract. [Comment]. Clin Pediatr 33:157-158.
4. Bryant HE, Visser N, Love EJ. 1989. Records, recall loss, and recall bias in pregnancy: a comparison of interview and medical records data of pregnant and post-natal women. Am J Public Health 79:78-80.
5. Burrow CR. 2000. Regulatory molecules in kidney development [Review]. Pediatr Nephrol 14:240-253.
6. Buttar HS. 1997. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development [Review]. Mol Cell Biochem 176:61-71.
7. California Birth Defects Monitoring Program. Available at: http://www.cb-dmp.org/bd_kidney.htm (accessed Sept 30 2003)
8. Centers for Disease Control and Prevention. 1997. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy-United States, Canada, and Israel, 1987-1995. Morb Mortal Wkly Rep 46:240-242.
9. Chambers CD, Johnson KA, Dick LM, et al. 1998. Maternal fever and birth outcome: a prospective study. Teratology 58:251-257.
10. Chavez GF, Mulinare J, Cordero JF. 1989. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 262:795-798.
11. Corby DG. 1978. Aspirin in pregnancy: maternal and fetal effects [Review]. Pediatrics 62:930-937.
12. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. 2001a. The teratogenic risk of trimethoprim-sulfonamides: a population-based case-control study. Reprod Toxicol 15:637-646.
13. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. 2001b. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 185:140-147.
14. Edmonds LD, Layde PM, James LM, et al. 1981. Congenital malformations surveillance: two American systems. Int J Epidemiol 10:247-252.
15. Edwards MJ, Shiota K, Smith MS, Walsh DA. 1995. Hyperthermia and birth defects. [Review]. Reprod Toxicol 9:411-425.
16. Edwards MJ. 1998. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links? [Review]. Cell Stress Chaperones 3:213-220.
17. Erickson JD, Mulinare J, McClain PW, et al. 1984. Vietnam veterans' risks for fathering babies with birth defects. JAMA 252:903-912.
18. Erickson JD. 1991. Risk factors for birth defects: data from the Atlanta birth defects case-control study. Teratology 43:41-51.
19. Gibson CS, Maclennan AH, Goldwater PN, Dekker GA. 2003. Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstet Gynecol Surv 58:209-220.
20. Graham JM Jr, Edwards MJ, Edwards MJ. 1998. Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans [Review]. Teratology 58:209-221.
21. Gupta C, Jaumotte J. 1993. Epidermal growth factor binding in the developing male reproductive duct and its regulation by testosterone. Endocrinology 133:1778-1782.
22. Harris J, Robert E, Kallen B. 2000. Epidemiologic characteristics of kidney malformations. Eur J Epidemiol 16:985-992.
23. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. 2000. Folic acid antagonists during pregnancy and the risk of birth defects [Comment]. N Engl J Med 343:1608-1614.
24. Hinoue A, Fushiki S, Nishimura Y, Shiota K. 2001. In utero exposure to brief hyperthermia interferes with the production and migration of neocortical neurons and induces apoptotic neuronal death in the fetal mouse brain. Brain Res Dev Brain Res 132:59-67.
25. Honein MA, Moore CA, Watkins ML. 2003. Subfertility and prepregnancy overweight/obesity: possible interaction between these risk factors in the etiology of congenital renal anomalies. Birth Defects Res Part A Clin Mol Teratol 67:572-577.
26. Khan VR, Brown IR. 2002. The effect of hyperthermia on the induction of cell death in brain, testis, and thymus of the adult and developing rat. Cell Stress Chaperones 7:73-90.
27. Kozer E, Nikfar S, Costei A, et al. 2002. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187:1623-1630.
28. Kurppa K, Holmberg PC, Kuosma E, et al. 1991. Anencephaly and maternal common cold. Teratology 44:51-55.
29. Langley-Evans SC, Welham SJ, Jackson AA. 1999. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 64:965-974.
30. Layde PM, Edmonds LD, Erickson JD. 1980. Maternal fever and neural tube defects. Teratology 21:105-108.
31. Lezcano L, Antia DE, Sahdev S, Jhaveri M. 1994. Crossed renal ectopia associated with maternal alkaloid cocaine abuse: a case report. J Perinatol 14:230-233.
32. Li DK, Checkoway H, Mueller BA. 1995a. Electric blanket use during pregnancy in relation to the risk of congenital urinary tract anomalies among women with a history of subfertility [Comment]. Epidemiology 6:485-489.
33. Li DK, Daling JR, Mueller BA, et al. 1995b. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies [Comment]. Teratology 51:30-66.
34. Li DK, Daling JR, Mueller BA, et al. 1995c. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies [Comment]. Epidemiology 6:212-218.
35. Li DK, Mueller BA, Hickok DE, et al. 1996. Maternal smoking during pregnancy and the risk of congenital urinary tract anomalies. Am J Public Health 86:249-253.
36. Li DK. 1999. Maternal history of subfertility and the risk of congenital urinary tract anomalies in offspring. Epidemiology 10:80-82.
37. Lynberg MC, Khoury MJ, Lu X, Cocian T. 1994. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 140:244-255.
38. MacKenzie JS, Houghton M. 1974. Influenza infections during pregnancy: association with congenital malformations and with subsequent neoplasms in children, and potential hazards of live virus vaccines [Review]. Bacteriol Rev 38:356-370.
39. Martinez-Frias ML, Rodriguez-Pinilla E, Prieto L. 1997. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology 56:241-243.
40. Mastrobattista JM. 1997. Angiotensin converting enzyme inhibitors in pregnancy [Review]. Semin Perinatol 21:124-134.
41. Mitchell AA, Cottler LB, Shapiro S. 1986. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123:670-676.
42. Moncada S, Vane JR. 1978. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane a2, and prostacyclin [Review]. Pharmacol Rev 30:293-331.
43. Moore CA, Khoury MJ, Liu Y. 1997. Does light-to-moderate alcohol consumption during pregnancy increase the risk for renal anomalies among offspring? Pediatrics 99:E11.
44. Morris SJ, Price GE, Barnett JM, et al. 1999. Role of neuraminidase in influenza virus-induced apoptosis. J Gen Virol 80:137-146.
45. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T. 2000. In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol 11:874-884.
46. Paganini-Hill A, Ross RK. 1982. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 116:114-122.
47. Ratnapalan S, Koren G. 2002. Taking ACE inhibitors during pregnancy. Is it safe? [Review]. Can Fam Physician 48:1047-1049.
48. Reiter RJ. 1993. Electromagnetic fields and melatonin production. Biomed Pharmacother 47:439-444.
49. Rossoni G, Omini C, Vigano T, et al. 1980. Bronchoconstriction by histamine and bradykinin in guinea pigs: relationship to thromboxane a2 generation and the effect of aspirin. Prostaglandins 20:547-557.
50. Saxen L, Holmberg PC, Kurppa K, et al. 1990. Influenza epidemics and anencephaly. Am J Public Health 80:473-475.
51. Schoenfeld A, Bar Y, Merlob P, Ovadia Y. 1992. NSAIDS: maternal and fetal considerations [Review]. Am J Reprod Immunol (Copenh) 28:141-147.
52. Shaw GM, Todoroff K, Velie EM, Lammer EJ. 1998. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 57:1-7.
53. Shindo T, Kurihara H, Kuno K, et al. 2000. Adamts-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function [Comment]. J Clin Invest 105:1345-1352.
54. Stewart AB, Inskeep EK, Townsend EC, Dailey RA. 2003. Effects of gram-positive bacterial pathogens in ewes: peptidoglycans as a potential mediator of interruption of early pregnancy. Reproduction 125:295-299.
55. Stoll C, Alembic Y, Roth MP, et al. 1990. Risk factors in urinary system malformations. Pediatric Nephrol 4:319-323.
56. Uncu Y, Uncu G, Esmer A, Bilgel N. 2002. Should asymptomatic bacteriuria be screened in pregnancy? Clin Exp Obstet Gynecol 29:281-285.
57. Van Allen MI. 1992. Structural anomalies resulting from vascular disruption. Pediatr Clin North Am 39:255-277.
58. Woolf AS, Welham SJ. 2002a. Cell turnover in normal and abnormal kidney development [Review]. Nephrol Dial Transplant 17 Suppl 9:2-4.
59. Woolf AS, Winyard PJ. 2002b. Molecular mechanisms of human embryogenesis: developmental pathogenesis of renal tract malformations [Review]. Pediatr Dev Pathol 5:108-129.
60. Yoon PW, Bresee JS, Olney RS, et al. 1997. Epidemiology of biliary atresia: a population-based study. Pediatrics 99:376-382.
61. Zhang J, Cai WW. 1993. Association of the common cold in the first trimester of pregnancy with birth defects. Pediatrics 92:559-563.